AstraZeneca PLC (AZNCF)
Data as of September 4, 2026 · Drug Manufacturers - General
Stockbruh grade: Challenging 1/5 metrics rated Sunny
What does AstraZeneca PLC do?
AstraZeneca, a biopharmaceutical company based in Cambridge, UK, focuses on developing and commercializing prescription medicines. Their wide range of products includes treatments for oncology, cardiovascular diseases, respiratory and immunology conditions, rare diseases, and even Covid-19. Serving physicians worldwide, AstraZeneca collaborates with other companies to advance research and develop innovative therapies. 💊🌍.
Key Numbers
| Metric | Rating | What it means |
|---|
| Returns (5Y) | ⛅ Moderate | 5-year price performance |
| Profitability | ☀️ Strong | Net margin & return on equity |
| Growth | ⛅ Moderate | Revenue & earnings trend |
| Earnings | ⛅ Moderate | EPS vs analyst expectations |
| Cash & Debt | ⛅ Moderate | Balance sheet strength |
| Price | $202.83 | Market Cap | — |
| Exchange | Other OTC | | |
Plain-English Analysis
What's it worth?
Performance has been moderate. Sign up free to see Stockbruh's full valuation analysis including price ratios and plain-English commentary.
How the business works
AstraZeneca, a biopharmaceutical company based in Cambridge, UK, focuses on developing and commercializing prescription medicines. Their wide range of products includes treatments for oncology, cardiovascular diseases, respiratory and immunology conditions, rare diseases, and even Covid-19. Sign up free for competitor and revenue breakdown ↗
Are they building the future?
Growth is mixed — some positive signals, but not consistent. Sign up free for Stockbruh's full growth breakdown.
What's ahead?
Earnings are mixed. Sign up free for the full earnings picture including EPS history and analyst forecasts.